A myocardial infarction, commonly referred to as a heart attack, transpires when a section of the heart muscle is obstructed due to the presence of a blood clot, disrupting the normal blood flow. This blockage can damage or destroy part of the heart muscle, leading to severe complications or even death if not treated promptly. Characteristic symptoms of a heart attack encompass chest pain or discomfort, shortness of breath, nausea, lightheadedness, and pain or discomfort radiating into the arms, back, neck, jaw, or stomach.. Swift medical intervention is imperative in the case of a heart attack to minimize potential damage to the heart muscle.. Treatment may involve medications, medical procedures such as angioplasty or stent placement to restore blood flow, and lifestyle changes to reduce the risk of future cardiac events. Adopting a heart-healthy lifestyle, including a balanced diet, regular exercise, and stress management, is essential in preventing heart attacks and promoting overall cardiovascular health. Understanding the risk factors and recognizing the warning signs can empower individuals to take proactive steps in safeguarding their heart health.
Title : Frequency of residual risk in cardiovascular secondary prevention in patients treated at the Reina Fabiola University Clinic
Agustin Joison, Cordoba Catholic University, Argentina
Title : Revolutionizing heart health through Personalized & Precision Medicine (PPM): Towards personalized cardiovascular prevention, precision cardiac care & rehabilitation via optimizing Cardiac Hospital Networks
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Antibody-proteases as unique biomarkers, potential targets and translational tools of the next step generation to be used in personalized and precision cardiology practice
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Investigation of bergapten’s pharmacological activity against doxorubicin induced cardiotoxicity: supporting evidence from cellular and animal models
Bijoy Krishna Banik, National Institute of Pharmaceutical Education and Research (NIPER)-Guwahati, India